Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have
relapsed or refractory multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)